Expressive suppression in psychosis: The association with social context.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
07
2019
accepted:
21
02
2020
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
23
6
2020
Statut:
epublish
Résumé
As emotion regulation deficits have been implicated in psychotic disorders, it is imperative to investigate not only the effect of regulation strategies but also how they are used. One such strategy is expressive suppression, the inhibition of emotion-expressive behavior, which may be influenced by social context. Therefore, this study aimed to investigate whether the use of expressive suppression was associated with social context and affect in daily life and if this differed between patients with psychosis and controls. Multilevel models using experience sampling method (ESM) data of 34 patients with psychotic disorders and 53 controls from the Genetic Risk and Outcome in Psychosis (GROUP) project were conducted. Expressive suppression and social context were assessed once a day for six days and daily affect was averaged per participant per day. Social context was significantly associated with the use of expressive suppression in daily life, so that the use of expressive suppression differed when in the presence of familiar versus non-familiar company when receiving negative feedback. This finding did not differ between patients and controls. This demonstrates that taking the situation into account when studying expressive suppression, and emotion regulation in general, may improve our understanding of how regulation takes place.
Identifiants
pubmed: 32160235
doi: 10.1371/journal.pone.0230102
pii: PONE-D-19-18758
pmc: PMC7065744
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0230102Déclaration de conflit d'intérêts
The GROUP study received funding from commercial sources: Lundbeck, AstraZeneca, Eli Lilly, and Janssen Cilag. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. All other authors report no financial interests or potential conflicts of interest.
Références
Soc Psychiatry Psychiatr Epidemiol. 2003 Nov;38(11):654-61
pubmed: 14614554
Psychiatry Res. 2011 Feb 28;185(3):303-8
pubmed: 20678808
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Psychiatry Res. 2012 Dec 30;200(2-3):193-201
pubmed: 22749227
Motiv Emot. 2017 Apr;41(2):230-242
pubmed: 28652647
Emotion. 2013 Oct;13(5):926-39
pubmed: 23731436
Emotion. 2013 Oct;13(5):803-10
pubmed: 24098929
Clin Psychol Psychother. 2009 Sep-Oct;16(5):418-30
pubmed: 19569041
Behav Res Ther. 2014 May;56:7-15
pubmed: 24632110
Cogn Emot. 2011 Aug;25(5):765-81
pubmed: 21824019
J Abnorm Psychol. 2008 May;117(2):473-478
pubmed: 18489225
J Pers Soc Psychol. 2003 Aug;85(2):348-62
pubmed: 12916575
Psychiatry Res. 2016 Oct 30;244:289-93
pubmed: 27512917
Psychol Med. 2009 Sep;39(9):1533-47
pubmed: 19215626
Psychol Assess. 2009 Dec;21(4):498-505
pubmed: 19947784
Psychiatry Res. 2009 Dec 30;170(2-3):108-13
pubmed: 19906439
J Sch Psychol. 2010 Feb;48(1):85-112
pubmed: 20006989
Int J Methods Psychiatr Res. 2012 Sep;21(3):205-21
pubmed: 22419500
Trends Cogn Sci. 2016 Jan;20(1):47-63
pubmed: 26564248
J Pers. 2008 Jun;76(3):561-80
pubmed: 18399953
Cogn Neuropsychiatry. 2016;21(2):116-29
pubmed: 26829655
Schizophr Res. 2014 Mar;153(1-3):32-7
pubmed: 24457036
Schizophr Bull. 2014 Mar;40(2):278-86
pubmed: 23407984
Acta Psychiatr Scand. 2003 Feb;107(2):124-31
pubmed: 12534438